Patent · US Active

CRTH2 modulators

US8674115B2 · kind B2 · utility

4Cited by

14References

42Claims

0Family size

Assignee

IRONWOOD PHARMACEUTICALS, INC. · US

Inventors

Ara Mermerian · Somerville, US
Bo Peng · Waltham, US
Colleen Hudson · Malden, US
Charles Kim · Cambridge, US
Joel Moore · Lexington, US
Jason Rohde · Poolesville, US
Kevin Sprott · Needham, US
Regina Graul · Duxbury, US
Takashi Nakai · Newton, US
James Jia · Somerville, US
Wilmin Bartolini · Amesbury, US

Key dates

Filing date	Dec 16, 2010
Grant date	Mar 18, 2014
Priority date	—
Expiry date	Dec 16, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modulators of CRTH2, particularly antagonists of CRTH2, that are useful for treating various disorders, including asthma and respiratory disorders are disclosed. The compounds fall within a genus described by formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.